These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18790815)

  • 21. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 22. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous coronary intervention in anticoagulated patients and balancing the risk of stroke and bleeding: to interrupt or not to interrupt?
    Wrigley BJ; Shantsila E; Lip GY
    Chest; 2010 Oct; 138(4):771-4. PubMed ID: 20923795
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 26. Long term anticoagulation or antiplatelet treatment. Patients at risk of stroke should be given warfarin.
    Evans A; Kalra L
    BMJ; 2001 Jul; 323(7306):234-5; author reply 235-6. PubMed ID: 11496886
    [No Abstract]   [Full Text] [Related]  

  • 27. Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.
    Jackson SL; Peterson GM
    J Clin Pharm Ther; 2011 Feb; 36(1):71-9. PubMed ID: 21198722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 29. Bleeding risk assessment and management in atrial fibrillation patients.
    Lip GY
    Eur Heart J; 2012 Jan; 33(2):147-9. PubMed ID: 22246817
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. My Approach to the use of NOACs for stroke prevention in patients with atrial fibrillation.
    Lip GY
    Trends Cardiovasc Med; 2014 Aug; 24(6):265-6. PubMed ID: 25106085
    [No Abstract]   [Full Text] [Related]  

  • 35. Atrial fibrillation: are there gender differences?
    Michelena HI; Ezekowitz MD
    J Gend Specif Med; 2000; 3(6):44-9. PubMed ID: 11253382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 37. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen JK; Cuisset T; Kirchhof P; Marín F;
    Eur Heart J; 2010 Jun; 31(11):1311-8. PubMed ID: 20447945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Which antithrombotic treatment in case of atrial fibrillation and coronary heart disease?].
    Fauchier L; Taillandier S; Clementy N
    Rev Prat; 2013 Feb; 63(2):200. PubMed ID: 23513781
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticoagulant management in patients with atrial fibrillation.
    Fitzmaurice DA; Hobbs FD
    Semin Thromb Hemost; 2009 Sep; 35(6):543-7. PubMed ID: 19787557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation, stroke and anticoagulation.
    Roy D; Mukherjee S; Chakravarty A
    J Assoc Physicians India; 2002 Sep; 50():1153-8. PubMed ID: 12516699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.